22nd Century Group, Inc.
Overview
22nd Century Group, Inc. is a biotechnology company focused on developing reduced nicotine tobacco and hemp/cannabis plant lines, with the aim of reducing the harm associated with tobacco and cannabis use. The company utilizes genetic engineering and plant breeding technologies to achieve these goals.
Therapeutic areas
Plant BiotechnologyTobacco Harm ReductionCannabis
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to 22nd Century Group, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.